Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: Arthritis Rheum. 2008 May 15;59(5):721–729. doi: 10.1002/art.23566

Table 2.

Characteristics of neuropsychiatric syndromes in SLE patients as indicated by the number of NP events and their attribution using attribution models

NP events (%) regardless of attribution NP events due to SLE (Model A) NP events due to SLE (Model B) NP events due to non-SLE causes
Headache 171 (42.0) 0 0 171
Mood disorders 67 (16.5) 3 22 45
Anxiety disorder 26 (6.4) 0 0 26
Cerebrovascular disease 23 (5.7) 8 22 1
Cognitive dysfunction 26 (6.4) 5 16 10
Seizure disorder 30 (7.4) 16 26 4
Acute confusional state 16 (3.9) 8 13 3
Polyneuropathy 10 (2.5) 3 6 4
Psychosis 9 (2.2) 3 8 1
Mononeuropathy 10 (2.5) 7 10 0
Cranial neuropathy 7 (1.7) 5 5 2
Aseptic meningitis 3 (0.7) 2 2 1
Myelopathy 5 (1.2) 4 5 0
Movement disorder 3 (0.7) 2 2 1
Autonomic disorder 1 (0.3) 1 1 0
Guillain-Barre syndrome 0 0 0 0
Demyelinating syndrome 0 0 0 0
Myasthenia gravis 0 0 0 0
Plexopathy 0 0 0 0
Total 407 67 138 269
*
The attribution of NP events to SLE was determined by two sets of decision rules of different stringency. NP events which fulfilled the criteria for Model A (the most stringent) or for Model B (the least stringent) were attributed to SLE. Those events which did not fulfill these criteria were attributed to non-SLE causes:
  • Attribution Model A: NP events which had their onset within the enrollment window and had no “exclusions” or “associations” and were not one of the NP events identified by Ainiala [1] were attributed to SLE.
  • Attribution Model B: NP events which had their onset within 10 years of the diagnosis of SLE and had no “exclusions” and were not one of the NP events identified by Ainiala [1] were attributed to SLE.